Adamis Pharmaceuticals reported $25M in Market Capitalization this December of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US USD 25M 5M
Adma Biologics ADMA:US USD 478M 89M
Brainstorm Cell Therapeutics BCLI:US USD 161M 60M
Cara Therapeutics CARA:US USD 577M 74M
GlaxoSmithKline GSK:LN GBP 58.86B 5.75B
Glaxosmithkline GSK:US GBP 71.2B 11.93B
Merk MRK:US USD 281.3B 63.14B
Pfizer PFE:US USD 287.63B 42.03B
Redhill Biopharma RDHL:US USD 32M 14M